Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Head/Neck
Head/Neck
This is a study to determine the clinical benefit (how well the drug works), safety and tolerability of combining CDX-3379 and cetuximab. The study will enroll patients with advanced head and neck squamous cell carcinoma who have previously received cetuximab and progressed.
Head/Neck
II
Gibson, Mike
NCT03254927
VICCHN1891
